ARCHIVES

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Committee Unblinds Phase III Zytiga Study

March 30, 2012

Also NCI prostate SPOREs plan biospecimen bank.

December 10, 2004

In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center

August 1, 1997

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

In Brief: Ultmann New AACI President, Robert Day Named President Elect; Hulka New DCPC Board Chairman

July 20, 1984

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989